Next, to further strengthen the role of BCRP/ABCG2 in influencing gefitinib sensitivity, the correlation between BCRP/ABCG2 expression and gefitinib sensitivity was evaluated in various lung cancer cell lines, which express either wild-type or mutated EGFR [25], [26]. This evidence concerns the gene EGFR and lung carcinoma.